Medicare Enrolled

Dr. Karine Kirakosyan, M.D.

Dermatology · Burbank, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
500 E OLIVE AVE, Burbank, CA 91501
8189721000
In practice since 2006 (19 years)
NPI: 1427092071 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kirakosyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirakosyan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kirakosyan

Dr. Karine Kirakosyan is a dermatology specialist in Burbank, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kirakosyan performed 1,506 Medicare services across 858 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kirakosyan received a total of $12,137 from 40 pharmaceutical and/or device companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kirakosyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in CA $12,137 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,506
Medicare services
Top 26% in CA for dermatology
858
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
569 $96 $250
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
225 $8 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
158 $68 $203
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
156 $27 $60
Annual depression screening 126 $21 $50
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
102 $140 $300
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
65 $16 $50
Venipuncture for blood draw
Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older.
46 $13 $50
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
23 $171 $300
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
13 $12 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
12 $146 $350
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $115 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,137
Total received (2018-2024)
Avg $1,734/year across 7 years
Top 4% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,137 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,648
2023
$1,522
2022
$1,672
2021
$2,213
2020
$1,971
2019
$1,625
2018
$1,486

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$522
GlaxoSmithKline, LLC.
$229
Amgen Inc.
$224
Phathom Pharmaceuticals, Inc.
$150
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
Sumitomo Pharma America, Inc.
$73
Ardelyx, Inc.
$58
ABBVIE INC.
$53
PFIZER INC.
$50
Novo Nordisk Inc
$46
Esperion Therapeutics, Inc.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
IRONWOOD PHARMACEUTICALS, INC
$22
Top 3 companies account for 59.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,729
AstraZeneca Pharmaceuticals LP
$1,938
GlaxoSmithKline, LLC.
$1,768
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$749
ABBVIE INC.
$599
AbbVie Inc.
$466
Takeda Pharmaceuticals U.S.A., Inc.
$410
Amgen Inc.
$286
Synergy Pharmaceuticals Inc
$266
Teva Pharmaceuticals USA, Inc.
$245
Lilly USA, LLC
$244
Allergan, Inc.
$230
Ironwood Pharmaceuticals, Inc
$200
Amarin Pharma Inc.
$171
IRONWOOD PHARMACEUTICALS, INC
$159
Phathom Pharmaceuticals, Inc.
$150
Esperion Therapeutics, Inc.
$136
AbbVie, Inc.
$119
Horizon Therapeutics plc
$110
Sumitomo Pharma America, Inc.
$102
Allergan Inc.
$98
Nestle HealthCare Nutrition Inc.
$86
Merck Sharp & Dohme Corporation
$77
Dexcom, Inc.
$76
PFIZER INC.
$69
Avanir Pharmaceuticals, Inc.
$66
Bayer HealthCare Pharmaceuticals Inc.
$62
Almatica Pharma LLC
$62
Orexo US, Inc.
$59
Biohaven Pharmaceuticals, Inc.
$59
Ardelyx, Inc.
$58
Biohaven Pharmaceutical Holding Company Ltd.
$48
Novo Nordisk Inc
$46
Sunovion Pharmaceuticals Inc.
$42
Horizon Pharma plc
$37
Kowa Pharmaceuticals America, Inc.
$34
Novartis Pharmaceuticals Corporation
$25
Corium, LLC
$22
Astellas Pharma US Inc
$20
DEXCOM, INC.
$16
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APRISO · Adlarity · AirDuo Digihaler · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · CREON · Creon · DEXCOM G6 TRANSMITTER · DUEXIS · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · FARXIGA · GEMTESA · IBSRELA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LOREEV XR · Linzess · Livalo · MOTEGRITY · MYRBETRIQ · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · ProAir Digihaler · QULIPTA · RAYOS · Repatha · SPIRIVA · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · Trintellix · Trulance · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · XIFAXAN · ZENPEP · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for dermatology in CA.

Looking for a dermatology specialist in Burbank?
Compare dermatologists in the Burbank area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
505
Per 100K population
5.1
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kirakosyan is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kirakosyan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kirakosyan performed 569 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirakosyan receive payments from pharmaceutical companies?
Yes. Dr. Kirakosyan received a total of $12,137 from 40 companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirakosyan's costs compare to other dermatologists in Burbank?
Dr. Kirakosyan's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirakosyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →